TY - JOUR
T1 - A Female Patient with Incomplete Hemophagocytic Lymphohistiocytosis Caused by a Heterozygous XIAP Mutation Associated with Non-Random X-Chromosome Inactivation Skewed Towards the Wild-Type XIAP Allele
AU - Yang, Xi
AU - Hoshino, Akihiro
AU - Taga, Takashi
AU - Kunitsu, Tomoaki
AU - Ikeda, Yuhachi
AU - Yasumi, Takahiro
AU - Yoshida, Kenichi
AU - Wada, Taizo
AU - Miyake, Kunio
AU - Kubota, Takeo
AU - Okuno, Yusuke
AU - Muramatsu, Hideki
AU - Adachi, Yuichi
AU - Miyano, Satoru
AU - Ogawa, Seishi
AU - Kojima, Seiji
AU - Kanegane, Hirokazu
N1 - Publisher Copyright:
© 2015, Springer Science+Business Media New York.
PY - 2015/3/18
Y1 - 2015/3/18
N2 - X-linked lymphoproliferative disease (XLP) is a rare inherited immunodeficiency that often leads to hemophagocytic lymphohistiocytosis (HLH). XLP can be classified as XLP1 or XLP2, caused by mutations in SH2D1A and XIAP, respectively. In women, X-chromosome inactivation (XCI) of most X-linked genes occurs on one of the X chromosomes in each cell. The choice of which X chromosome remains activated is generally random, although genetic differences and selective advantage may cause one of the X chromosomes to be preferentially inactivated. Here we describe three patients with pancytopenia, including one female patient, in a Japanese family with a novel XIAP mutation. All three patients exhibited deficient XIAP protein expression, impaired NOD2/XIAP signaling, and augmented activation-induced cell death. In the female patient, the paternally derived X chromosome was non-randomly and exclusively inactivated in her peripheral blood and hair root cells. In contrast to asymptomatic females, this patient exhibied non-random XCI skewed towards the wild-type XIAP allele. This is the first report of a female patient with incomplete HLH resulting from a heterozygous XIAP mutation in association with non-random XCI.
AB - X-linked lymphoproliferative disease (XLP) is a rare inherited immunodeficiency that often leads to hemophagocytic lymphohistiocytosis (HLH). XLP can be classified as XLP1 or XLP2, caused by mutations in SH2D1A and XIAP, respectively. In women, X-chromosome inactivation (XCI) of most X-linked genes occurs on one of the X chromosomes in each cell. The choice of which X chromosome remains activated is generally random, although genetic differences and selective advantage may cause one of the X chromosomes to be preferentially inactivated. Here we describe three patients with pancytopenia, including one female patient, in a Japanese family with a novel XIAP mutation. All three patients exhibited deficient XIAP protein expression, impaired NOD2/XIAP signaling, and augmented activation-induced cell death. In the female patient, the paternally derived X chromosome was non-randomly and exclusively inactivated in her peripheral blood and hair root cells. In contrast to asymptomatic females, this patient exhibied non-random XCI skewed towards the wild-type XIAP allele. This is the first report of a female patient with incomplete HLH resulting from a heterozygous XIAP mutation in association with non-random XCI.
KW - Hemophagocytic lymphohistiocytosis
KW - X-chromosome inactivation
KW - X-linked inhibitor of apoptosis
KW - X-linked lymphoproliferative syndrome
UR - http://www.scopus.com/inward/record.url?scp=84925536858&partnerID=8YFLogxK
U2 - 10.1007/s10875-015-0144-6
DO - 10.1007/s10875-015-0144-6
M3 - 学術論文
C2 - 25744037
AN - SCOPUS:84925536858
SN - 0271-9142
VL - 35
SP - 244
EP - 248
JO - Journal of Clinical Immunology
JF - Journal of Clinical Immunology
IS - 3
ER -